Piper Sandler analyst Kashy Harrison lowered the firm’s price target on Ameresco to $35 from $37 and keeps an Overweight rating on the shares following a mixed update from the company. EBITDA missed given SCE cost overruns, which also reduced FY24 EBITDA guidance by 2%. Ameresco also announced further SCE delays. Despite the lack of SCE cash tailwinds, the company’s adjusted CFO still improved significantly quarter-over-quarter and corporate leverage inched lower, Piper adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRC:
Questions or Comments about the article? Write to editor@tipranks.com